Download Free Sample Report

Protein Drugs Market, Global Outlook and Forecast 2023-2029

Protein Drugs Market, Global Outlook and Forecast 2023-2029

  • Published on : 20 May 2023
  • Pages :61
  • Report Code:SMR-7692982

Download Report PDF Instantly

Leave This Empty:

Secure

Report overview

A type of?drugs made of?protein. These?drugs usually have large molecular weight with?proteincharacteristics.
This report aims to provide a comprehensive presentation of the global market for Protein Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Protein Drugs. This report contains market size and forecasts of Protein Drugs in global, including the following market information:
Global Protein Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Protein Drugs market was valued at US$ 274630 million in 2022 and is projected to reach US$ 439490 million by 2029, at a CAGR of 6.9% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Antibody Drugs Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Protein Drugs include Eli Lilly, Abbott Laboratories, UCB Group, Schering-Plough Corporation, Genentech, Johnson?Johnson, Bristol-Myers Squibb, Novo Nordisk and Biogen Idec, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Protein Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Protein Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Protein Drugs Market Segment Percentages, by Type, 2022 (%)
Antibody Drugs
Peptide Hormones
Blood Products
Enzymes
Global Protein Drugs Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Protein Drugs Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Other
Global Protein Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Protein Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Protein Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Protein Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Eli Lilly
Abbott Laboratories
UCB Group
Schering-Plough Corporation
Genentech
Johnson?Johnson
Bristol-Myers Squibb
Novo Nordisk
Biogen Idec
Dendreon Corporation
Amgen Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Protein Drugs, market overview.
Chapter 2: Global Protein Drugs market size in revenue.
Chapter 3: Detailed analysis of Protein Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Protein Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.